Anti-heatstroke use of teprenone
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA
- Publication Date
- 2008-04-23
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention relates to an anti-heat stroke application of teprenone (digeranylacetone). Under the condition of oral administration, teprenone can significantly delay the occurrence of heatstroke in rats in a hot environment and prolong the survival time of heatstroke rats. Background technique
[0002] Preventive measures for thermal environment damage and heatstroke are important topics in environmental medicine, military medicine, and aerospace medicine. So far, there is still no satisfactory drug for preventing heatstroke.
[0003] Teprenone (geranylgeranylacetone, GGA) is a relatively safe HSP70 inducer, which is commonly used in the treatment of ulcer disease. Teprenone can reduce the cytotoxic effect (Bai, 2002) and neuron injury (Kikuchi, 2002) that chemical substance causes by inducing HSP70; Vestibular cell injury (Takumida, 2005), epilepsy (Fujiki, 2003; 2004), cerebral infarction (Nagai, 2005; Yasuda, 2005; Nikaido, 2004) and so on have ...